standard]
MAEIEFEAVLKFLRENGLSECESALMEDVMEKSQQGSSDFAKFFFPMVPP
PPPLRIPPTRRPPPHEFTDGGGDRSSKGSSDDEFVSLGSSTAELCFSGAD
FTNPYGIGASQPASQSSSDRLSQFGTARDYPDFDLQNDLFWYKENDEDYA
MPPFFGDRDFDADPSEDKFVMTVRTGVPVEHELKYSLISEESTNFLENGR
ALASRDDLKYEPCKDYYELDEKFQLEKCDKKCEEYCNGYSCSVPLCACCS
SVGRIYEGDPANYNLENLKVMDLHDYQSGPLGEEHTIIETNVSNQRSSTS
DCNGGFSSTHDSSNFKKDCQLKEDNNVDFMDDEVIADETHDAEASIDEED
GAIPDELMIYGNKGDNYEIFNLRIIHRKNRTGFEENKELPIVLNSVIAGR
YCVTEFLGSAAFSRVVQAHDLYSGMDVCLKIIKNDKDFFDQSLDEIKLLK
FVNKHDPADEHHILRLYDYFYHQEHLFIVTELLRANLYEFQKYNQESGGE
PYFTLHRLQVITQQCLEAVLYLHDLGIIHCDLKPENILIKSYRRCEIKVI
DLGSSCFQTDNLSLYVQSRSYRAPEVMLGLPYDQKIDLWSIGCILAELYS
GEVLFPNEAVVMLLARMIGLLGPIDMDMLQKGQETHKYFTKEYDLYYINE
EANQLEYVIPEESSLEHHLQISDPEFLDFLRYLLEINPERRPTAREALQH
PWLSHSYDV
|
IPR000719; Protein kinase, catalytic domain IPR002290; Serine/threonine-protein kinase domain IPR008271; Serine/threonine-protein kinase, active site IPR017442; Serine/threonine-protein kinase-like do |